Arcus Biosciences, Inc. (NYSE:RCUS) Q3 2024 Earnings Call Transcript November 6, 2024
Arcus Biosciences, Inc. beats earnings expectations. Reported EPS is $-1, expectations were $-1.07.
Operator: Good afternoon, thank you for attending today’s Arcus Biosciences Third Quarter 2024 Earnings Call. My name is Tamiya and I will be your moderator for today’s call. All lines will be muted during the presentation portion of the call, with an opportunity for questions and answers at the end....
